BNP Paribas Increases UnitedHealth Group Holdings to $6.68 Million

The institutional investor added 8,843 shares of the healthcare conglomerate's stock in the third quarter.

Mar. 15, 2026 at 9:08am

Got story updates? Submit your updates here. ›

BNP Paribas lifted its position in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 84.2% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor now owns 19,351 shares of the healthcare conglomerate's stock, valued at $6,680,000 as of the latest filing.

Why it matters

UnitedHealth Group is one of the largest healthcare companies in the United States, providing a wide range of insurance and healthcare services. Institutional investors like BNP Paribas closely monitor and adjust their holdings in the company, which can signal broader market trends and investor sentiment around the healthcare sector.

The details

BNP Paribas purchased an additional 8,843 shares of UnitedHealth Group stock in the third quarter, increasing its total position to 19,351 shares. The investment firm cited the healthcare conglomerate's strong financial performance and growth potential as reasons for the increased stake.

  • BNP Paribas filed its latest 13F report with the SEC on March 15, 2026, disclosing its Q3 2025 holdings.
  • The 84.2% increase in BNP Paribas' UnitedHealth Group position occurred during the third quarter of 2025.

The players

BNP Paribas

A French multinational bank and financial services company that is one of the largest institutional investors in UnitedHealth Group.

UnitedHealth Group Incorporated

A diversified healthcare company that provides insurance, healthcare services, and technology solutions in the United States and globally.

Got photos? Submit your photos here. ›

The takeaway

BNP Paribas' increased stake in UnitedHealth Group reflects the institutional investor's confidence in the healthcare company's long-term growth prospects, despite broader market volatility. This move aligns with broader trends of institutional investors closely monitoring and adjusting their positions in major healthcare industry players.